{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "be:ERK",
      "entity_text" : "MAPK",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:5291",
      "entity_text" : "Imatinib",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Other lead compounds that were already tested by us in in vitro systems for primary cells and metacestode vesicles were pyridinyl imidazoles, directed against p38 mitogen activated protein kinase (MAPK) [XREF_BIBR], Imatinib, and HNMPA (AM) 3.",
  "reading_complete" : "2020-08-02T10:16:54Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T10:10:36Z",
  "trigger" : "directed",
  "evidence" : [ "directed against p38 mitogen-activated protein kinase (MAPK) [ XREF_BIBR ], Imatinib" ],
  "pmc_id" : "4271656",
  "score" : 0
}